These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 20839062

  • 1. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
    McKenzie S, Mailey B, Artinyan A, Metchikian M, Shibata S, Kernstine K, Kim J.
    Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
    [Abstract] [Full Text] [Related]

  • 2. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
    Chao YK, Yeh CJ, Chang HK, Tseng CK, Chu YY, Hsieh MJ, Wu YC, Liu HP.
    Ann Surg Oncol; 2011 Feb; 18(2):529-34. PubMed ID: 20697822
    [Abstract] [Full Text] [Related]

  • 3. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E.
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [Abstract] [Full Text] [Related]

  • 4. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma.
    Yamamoto S, Ishihara R, Motoori M, Kawaguchi Y, Uedo N, Takeuchi Y, Higashino K, Yano M, Nakamura S, Iishi H.
    Am J Gastroenterol; 2011 Jun; 106(6):1048-54. PubMed ID: 21343920
    [Abstract] [Full Text] [Related]

  • 5. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy.
    Hirst J, Smithers BM, Gotley DC, Thomas J, Barbour A.
    Ann Surg Oncol; 2011 Jun; 18(6):1766-74. PubMed ID: 21213056
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of age in the radical treatment of oesophageal cancer with surgery or chemoradiotherapy: a prospective observational cohort study.
    Davies L, Lewis WG, Arnold DT, Escofet X, Blackshaw G, Gwynne S, Evans M, Roberts SA, Appadurai I, Crosby TD.
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):578-85. PubMed ID: 20591633
    [Abstract] [Full Text] [Related]

  • 9. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM.
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [Abstract] [Full Text] [Related]

  • 10. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD, Gaur P, Force SD, Staley CA, Mansour KA, Miller JI, Miller DL.
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
    Vallböhmer D, Hölscher AH, DeMeester S, DeMeester T, Salo J, Peters J, Lerut T, Swisher SG, Schröder W, Bollschweiler E, Hofstetter W.
    Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
    [Abstract] [Full Text] [Related]

  • 14. [Current diagnosis and therapy of esophageal carcinoma].
    Mühr-Wilkenshoff F, Stahl M, Faiss S, Zeitz M, Scherübl H.
    Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
    [Abstract] [Full Text] [Related]

  • 15. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ, Ceppa D, Okereke I, Rieger KM, Jalal SI, LeBlanc JK, DeWitt JM, Kesler KA, Birdas TJ.
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [Abstract] [Full Text] [Related]

  • 16. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR.
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [Abstract] [Full Text] [Related]

  • 17. [A prospective comparison between surgery alone and postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma].
    Cao XF, Lü J, Zhu B, An HY, Wang S, Wu BC, Ji L, Tao L, Wang DD.
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):452-5. PubMed ID: 20819489
    [Abstract] [Full Text] [Related]

  • 18. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H, Farrell JJ, Crane CH.
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract] [Full Text] [Related]

  • 19. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
    Barthel JS, Kucera ST, Lin JL, Hoffe SE, Strosberg JR, Ahmed I, Dilling TJ, Stevens CW.
    Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
    [Abstract] [Full Text] [Related]

  • 20. Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patterns.
    Koshy M, Greenwald BD, Hausner P, Krasna MJ, Horiba N, Battafarano RJ, Burrows W, Suntharalingam M.
    Am J Clin Oncol; 2011 Jun; 34(3):259-64. PubMed ID: 20686405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.